OTC · Medical - Devices

BICO Group AB (publ) (BCCOY) Stock

$0.37 +0.00% OTC: BCCOY Healthcare

BICO Group AB (publ), originally founded in 2016 as Cellink AB (publ) in Gothenburg, Sweden, and subsequently renamed in August 2021, functions as a bio-convergence leader. The company extends its operations internationally, with a presence spanning North America, Europe, and Asia.

Valuation

MetricValue
Price$0.37
Market Cap$104.11M
P/E Ratio-1.07
P/B Ratio0.65
P/S Ratio0.69
EPS (TTM)$-3.59
52-Week High$0.80
52-Week Low$0.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-51.81%
ROA-33.20%
ROCE-10.08%
Gross Margin44.96%
Operating Margin-16.32%
Net Margin-66.09%
Debt/Equity0.43
Current Ratio2.35

Annual Financials (USD)

Metric20202021202220242025
Revenue$177.0M$1.3B$2.2B$1.9B$1.4B
Operating Profit$-66.0M$-160.0M$-618.0M$-289.0M$-237.0M
Net Profit$-62.0M$-229.0M$-836.0M$-5.0M$-1.0B
EPS$-0.37$-0.93$-3.12$0.00$-3.59
Op Margin-37.4%-12.7%-27.6%-14.8%-16.8%

Balance Sheet (USD)

Metric20202021202220242025
Total Assets$1.6B$9.8B$10.2B$5.5B$3.7B
Total Liabilities$127.0M$3.0B$3.3B$2.5B$1.9B
Cash$809.0M$481.0M$925.0M$598.0M$1.3B
Borrowings$62.0M$1.6B$1.9B$1.8B$1.5B

Cash Flow (USD)

Metric20202021202220242025
Operating Cash Flow$-72.0M$-409.0M$-269.0M$158.0M$64.0M
Investing Cash Flow$-283.0M$-4.7B$-317.0M$84.0M$653.0M
Financing Cash Flow$-41.0M$-135.0M$-81.0M$3.0M$-101.0M
Net Cash Flow$769.0M$46.0M$444.0M$85.0M$493.0M
Free Cash Flow$-154.0M$-676.0M$-799.0M$114.0M$52.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.92
FCF Yield2.35%
Quick Ratio1.99
Interest Coverage-1.42
Return 1Y-53.90%
Return 3Y-52.20%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACMLFAscom Holding AG $4.37 +0.00% 10.60 $149.28M 5.72%
BRIBFBrii Biosciences Limited $0.13 +0.00% -2.71 $90.69M 0.00%
CYBQFCYBERDYNE Inc. $1.55 +19.23% 305.56 $206.82M 0.00%
MLLCFMolecular Partners AG $3.80 +0.00% -2.13 $142.54M 0.00%
NDTPNDT Pharmaceuticals Inc. $0.55 -0.36% -421.54 $87.68M 0.00%

About BICO Group AB (publ)

BICO Group AB (publ), originally founded in 2016 as Cellink AB (publ) in Gothenburg, Sweden, and subsequently renamed in August 2021, functions as a bio-convergence leader. The company extends its operations internationally, with a presence spanning North America, Europe, and Asia. Its business is structured into two primary divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions segment provides sophisticated scientific equipment, including 3D bioprinters, hybrid microscopes, single-cell dispensing devices, and liquid handling instruments. This division also supplies critical consumables such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues, particularly those utilized in regulatory testing. Furthermore, it offers specialized services in areas like 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology, primarily serving pharmaceutical and biotechnology enterprises. In contrast, the Bioautomation segment delivers precision dispensing and biosensor technologies to industrial customers. It also provides advanced robotics and diagnostics automation solutions tailored for the medical and diagnostic sectors. Beyond these, this segment develops comprehensive solutions encompassing core industrial ecosystems, tissue engineering, multi-omics, cell line development, and diagnostics. Its main clientele comprises the medical, pharmaceutical, and cosmetic industries.

BICO Group AB (publ) is headquartered in SE.

BICO Group AB (publ) (BCCOY) stock trades at $0.37 with a market capitalization of $104.11M. The stock is valued at a price-to-earnings (P/E) ratio of -1.07, price-to-book of 0.65, price-to-sales of 0.69. Over the past 52 weeks the stock has ranged between $0.37 and $0.80, and currently trades 53.8% below its 52-week high.

On profitability, BICO Group AB (publ) generates a return on equity (ROE) of -51.81%, return on capital employed of -10.08%, an operating margin of -16.32%, a net profit margin of -66.09%.

Official website: www.bico.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides